Denise Braendgaard: Turning ISTH 2026 Connections into Better Patient Care
Denise Braendgaard, General Manager at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, commented on Njuguna Githinji’s post on LinkedIn, adding:
“Warm welcome to the NNHF team.
Thank you for all the insightful discussions at the congress and for naturally engaging the NNHF way!”
Njuguna Githinji, Classical Hematology Programs Coordinator at AMPATH Kenya, shared a post on LinkedIn:
“What am I taking home from ISTH 2026?
Not just notes from inspiring scientific sessions, but fresh ideas, meaningful connections, and a renewed sense of purpose.
Starting my journey as Program Manager for East Africa at the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, this congress was the perfect place to listen, learn, and connect with experts and partners from across the globe.
Now comes the most important part: turning those conversations into action and working together with partners to improve access to care and outcomes for people living with heamophilia and haemoglobinopathies.
Looking forward to what comes ahead!”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight